(Total Views: 91)
Posted On: 02/06/2024 12:57:29 PM
Post# of 25660

$NBIO - Nascent CEO, Sean Carrick, commented: "We are thrilled to unlock the full disruptive potential of pritumumab against cancer by collaborating with Manhattan Bio's world-leading scientists."
https://finance.yahoo.com/news/nascent-biotec...00090.html
https://finance.yahoo.com/news/nascent-biotec...00090.html

